Loading...
Please wait, while we are loading the content...
Similar Documents
Antitrust Issues Involving the Pharmaceutical , Biotechnology , and Medical Device Industries : Skillfully Navigating Rough Waters
| Content Provider | Semantic Scholar |
|---|---|
| Copyright Year | 2009 |
| Abstract | tiny over the past decade in the United States as the pharmaceutical industry. Unwarranted hostility to intellectual property rights, unrealistic expectations of lowcost access to high-value, high-cost pharmaceutical products, and the lure of treble damages have led to a dramatic and arguably unjustifiable expansion of U.S. public and private antitrust enforcement in the pharmaceutical industry. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://www.jonesday.com/files/Publication/344a5f17-8b68-483f-b1c5-72b747e38b62/Presentation/PublicationAttachment/a0e878a2-54b4-41dc-90d1-7401e0ead5da/Antitrust_Pharmaceutical.pdf |
| Alternate Webpage(s) | https://www.jonesday.com/files/Publication/344a5f17-8b68-483f-b1c5-72b747e38b62/Presentation/PublicationAttachment/d665015e-6d0b-452a-8b48-a2ced71347ad/Antitrust_Pharmaceutical.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |